Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis.
Saved in:
| Title: | Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis. |
|---|---|
| Authors: | Devjani S; SUNY Downstate College of Medicine, New York, NY, USA., Engel PV; California University of Science and Medicine, Colton, CA, USA., Javadi SS; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Smith B; Drexel University College of Medicine, Drexel University, Philadelphia, PA, USA., Wu JJ; Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: jashinwu@gmail.com. |
| Source: | Lancet (London, England) [Lancet] 2023 Nov 18; Vol. 402 (10415), pp. 1833-1834. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
